Progression of Coronary Atherosclerosis After Heart Transplantation on Electron-beam Computed Tomography

Academic Radiology

Volumn 16, Issue 2, 2009, Pages 194-199

  Knollmann, Friedrich D ^a   Stühmer, Franziska ^b   Lehmkuhl, Hans ^c   Felix, Roland ^b   Hetzer, Roland ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b HUMBOLDT UNIVERSITY   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

computed tomography; coronary disease; Heart transplantation

Indexed keywords

CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DRUG EFFECT; ELECTRON BEAM TOMOGRAPHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE;

ADOLESCENT; ADULT; AGED; CAUSALITY; CHILD; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HEART TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58049205554     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2008.07.014     Document Type: Article

References (23)

1. Hosenpud J.D., Bennet L.E., Keck B.M., Fiol B., Boucek M.M., and Novick R.J. The registry of the International Society for Heart and Lung Transplantation: sixteenth official report-1999. J Heart Lung Transplant 18 (1999) 611-626
2. St. Goar F.G., Pinto F.J., Alderman E.L., et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of "angiographically silent" intimal thickening. Circulation 85 (1992) 979-987
3. Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
4. Ramzy D., Rao V., Brahm J., Mirikuga S., Delgado D., and Ross H.J. Cardiac allograft vasculopathy: a review. Can J Surg 48 (2005) 319-327
5. Budoff M.J., Georgiou D., Brody A., et al. Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease. Circulation 93 (1996) 898-904
6. Knollmann F.D., Bocksch W., Spieglsberger S., Hetzer R., Felix R., and Hummel M. Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation. Circulation 101 (2000) 2078-2082
7. Farzaneh-Far A. Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation (letter to the editor). Circulation 103 (2001) e60
8. Knollmann F.D., Felix R., Bocksch W., Spiegelsberger S., Hummel M., and Hetzer R. Electron-beam computed tomography in the assessment of coronary artery disease after heart transplantation (letter to the editor). Circulation 103 (2001) e60
9. Callister T.Q., Raggi P., Cooil B., Lippolis N.J., and Russo D. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339 (1998) 1972-1978
10. Koashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
11. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., and Detrano F. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
12. Budoff M.J., Lane K.L., Bakhsheshi H., et al. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol 86 (2000) 8-11
13. Achenbach S., Ropers D., Pohle K., et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification. Circulation 106 (2002) 1077-1082
14. Grauhan O., Patzurek J., Hummel M., et al. Donor-transmitted coronary atherosclerosis. J Heart Lung Transplant 22 (2003) 568-573
15. Rumberger J.A., and Kaufman L. A Rosetta stone for coronary calcium risk stratification: Agatston, volume and mass scores in 11490 individuals. AJR Am J Roentgenol 181 (2003) 743-748
16. Schmermund A., Erbel R., and Silber S. Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2030 persons with no symptoms of coronary artery disease. Am J Cardiol 90 (2002) 168-173
17. Yoon H.C., Emerick A.M., Hill J.A., Gjertson D.W., and Goldin J.G. Calcium begets calcium: progression of coronary artery calcification in asymptomatic subjects. Radiology 224 (2002) 236-241
18. Rahnami M., Cruz R.P., Granville D.J., and McManus B.M. Allograft vasculopathy versus atherosclerosis. Circ Res 99 (2006) 801-815
19. Li H., Tanaka K., Anzai H., et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes of heart transplant recipients. J Am Coll Cardiol 47 (2006) 2470-2476
20. Schmermund A., Achenbach S., Budde T., et al. Effect of intensive standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months. Circulation 113 (2006) 427-437
21. Arad Y., Spadaro L.A., Roth M., Newstein D., and Guerci A.D. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 46 (2005) 166-172
22. Raggi P., Davidson M., Callister T.Q., et al. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering With EBT Scanning (BELLES). Circulation 112 (2005) 563-571
23. Redberg R.F. Coronary artery calcium-should we rely on this surrogate marker?. Circulation 113 (2006) 336-337